insights_auto
Why is EMCURE up 4,57%?
Dive Deeperchevron_right
EMCURE:NSE
Emcure Pharmaceuticals Ltd
2 334,40 ₹
arrow_upward
+4,57%(+102,00) 1D
12 նոյ, 15:30:02 GMT+5:30 · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
2 260,00 ₹
High
2 344,40 ₹
Low
2 243,60 ₹
Mkt. cap
442,86 մլրդ
Avg. vol.
198,40 հզր
Volume
964,93 հզր
Dividend
0,15%
Quarterly dividend
0,90 ₹
Ex-dividend date
04 սեպ, 2026 թ.
P/E ratio
49,00
52-wk high
2 429,90 ₹
52-wk low
1 312,30 ₹
EPS
47,64 ₹
No. of employees
7 հզր
Open
2 260,00 ₹
High
2 344,40 ₹
Low
2 243,60 ₹
Mkt. cap
442,86 մլրդ
Avg. vol.
198,40 հզր
Volume
964,93 հզր
Dividend
0,15%
Quarterly dividend
0,90 ₹
Ex-dividend date
04 սեպ, 2026 թ.
P/E ratio
49,00
52-wk high
2 429,90 ₹
52-wk low
1 312,30 ₹
EPS
47,64 ₹
No. of employees
7 հզր
News stories
From web sources and news partners
24/7 Wall St.
·
51 րոպե առաջ
America's Biggest Bank Turned $1,000 Into $5,559 in Ten Years, Beating the S&P 500 by $1,519
FOREX.com
·
5 ժամ առաջ
S&P 500 Forecast: SPX falls as Nvidia tanks on CEO Huang’s resignation
ChartMill
·
1 ժամ առաջ
Most Active S&P 500 Stocks: KDP, Ford, AT&T Lead Today's Session
The Motley Fool
·
2 ժամ առաջ
The S&P 500 Is Hiding a Sneaky Risk. Here's How Investors Can Prepare for Potential Volatility.
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees6,91 հզր
Founded16 ապր, 1981 թ.
Headquarters-
SectorHealth Care
Industry-
Websiteemcure.com